QQ客服 官方微博 反馈留言

浏览/检索结果: 共5条，第1-5条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 A phase I study of AST1306, a novel irreversible EGFR and HER2 kinase inhibitor, in patients with advanced solid tumors 期刊论文 JOURNAL OF HEMATOLOGY & ONCOLOGY, 2014, 卷号: 7 作者:  Zhang, Jian;  Cao, Junning;  Li, Jin;  Zhang, Yifan;  Chen, Zhiyu 收藏  |  浏览/下载：18/0  |  提交时间：2019/01/08 AST1306  ErbB family  Irreversible tyrosine kinase inhibitor  Phase I   A phase I study of AST1306, a novel irreversible EGFR and HER2 kinase inhibitor, in patients with advanced solid tumors 期刊论文 JOURNAL OF HEMATOLOGY & ONCOLOGY, 2014, 卷号: 7 作者:  Zhang, Jian;  Cao, Junning;  Li, Jin;  Zhang, Yifan;  Chen, Zhiyu 收藏  |  浏览/下载：10/0  |  提交时间：2019/12/19 AST1306  ErbB family  Irreversible tyrosine kinase inhibitor  Phase I   Development and validation of a sensitive LC-MS/MS assay for the simultaneous quantification of allitinib and its two metabolites in human plasma 期刊论文 JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2013, 卷号: 86, 页码: 49-55 作者:  Lin, Lishan;  Gao, Zhiwei;  Chen, Xiaoyan;  Zhong, Dafang 收藏  |  浏览/下载：16/0  |  提交时间：2019/01/08 Liquid chromatography-tandem mass spectrometry  Allitinib  Metabolite  Pharmacokinetics  Human plasma   AST1306, A Novel Irreversible Inhibitor of the Epidermal Growth Factor Receptor 1 and 2, Exhibits Antitumor Activity Both In Vitro and In Vivo 期刊论文 PLOS ONE, 2011, 卷号: 6, 期号: 7 作者:  Xie, Hua;  Lin, Liping;  Tong, Linjiang;  Jiang, Yong;  Zheng, Mingyue 收藏  |  浏览/下载：25/0  |  提交时间：2019/01/08 AST1306, A Novel Irreversible Inhibitor of the Epidermal Growth Factor Receptor 1 and 2, Exhibits Antitumor Activity Both In Vitro and In Vivo 期刊论文 PLOS ONE, 2011, 卷号: 6, 期号: 7 作者:  Xie, Hua;  Lin, Liping;  Tong, Linjiang;  Jiang, Yong;  Zheng, Mingyue 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05